Category: patient

analysis, analytics, business, Business Analysis, CANADA, cannabis, cbd, compliance, consumer, cultivation, Cultivation & Growing, dispensary, distribution, distributor, domestic, EU, europe, European, export, extraction, Federal, foreign, German, Germany, government, growing, import, importer, industry, insurance, insure, insurer, international, law, legal, legalization, legalize, legislation, license, licensed, licensee, licensing, marijuana, market, medical, medicine, patient, process, product, Product Development, Quality, regulation, regulations, regulatory, retail, safety, specialty, Standardization, state, test, thc, union

Shakeups In The German Cannabis Market

Shakeups In The German Cannabis Market

As Germany begins to enter a summer where life seems ever more normal, there are fairly major shakeups underway in the German […]

agreement, analysis, analytics, Aussie, Australia, Australian, British, business, Business Analysis, CANADA, canadian, cannabinoid, cannabis, cbd, clinic, compliance, consumer, cooperation, cultivation, drug, England, Epidiolex, EU, europe, European, export, Federal, firm, German, Germany, global, government, growing, GW Pharma, GW Pharmaceuticals, healthcare, hospital, import, industry, insurance, insure, international, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, network, NHS, patient, pharmacies, pharmacy, pool, prescribe, prescription, producer, product, production, Quality, regulation, regulations, regulatory, retail, Sativex, state, thc, THC Global, UK, union, United Kingdom, wide, world

Will Australia’s Cannabis Program Follow Canada’s Lead?

Will Australia’s Cannabis Program Follow Canada’s Lead?

The news is intriguing in a world overwhelmed with pandemic news. THC Global, a Canadian-Aussie company now raising money and signing global […]